Now that Fred Hassan is no longer the chief executive of Schering-Plough - or any other drugmaker - since Merck finally scooped up its rival, Fred has been busy accepting invitations to join the boards of various other corporations. Apparently, his experience selling drugmakers - don't forget his time running Pharmacia - is seen as invaluable to others who want to increase their stock prices.
Last week, for instance, Fred joined the Warbug Pincus private equity firm as a senior advisor (please look here) and joined the board of Bausch & Lomb, which makes eye products (see here). And late last month, he became a Time Warner board member (statement). And for those who weren't aware, Fred is already an Avon Products board member.
But where will Fred turn up next? Suggestions? Please write in. We will forward them.